publication venue for
- Molecular characteristics and outcomes in Hispanic and non-Hispanic patients with acute myeloid leukemia.. 3. 2022
- Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment.. 3. 2022
- A novel SF3B1 variant in a patient with MDS with ring sideroblasts.. 3. 2022
- Gene expression profiling impacts treatment decision making in newly diagnosed multiple myeloma patients in the prospective PROMMIS trial.. 2. 2021
- Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry.. 1. 2020